SK42593A3 - Antitusic agents - Google Patents

Antitusic agents Download PDF

Info

Publication number
SK42593A3
SK42593A3 SK42593A SK42593A SK42593A3 SK 42593 A3 SK42593 A3 SK 42593A3 SK 42593 A SK42593 A SK 42593A SK 42593 A SK42593 A SK 42593A SK 42593 A3 SK42593 A3 SK 42593A3
Authority
SK
Slovakia
Prior art keywords
per dose
dose
composition
per
sodium
Prior art date
Application number
SK42593A
Other languages
English (en)
Slovak (sk)
Inventor
Ronald L Smith
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of SK42593A3 publication Critical patent/SK42593A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SK42593A 1990-10-31 1991-10-21 Antitusic agents SK42593A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60629490A 1990-10-31 1990-10-31
PCT/US1991/007773 WO1992007559A1 (en) 1990-10-31 1991-10-21 Dextromethorphan antitussive compositions

Publications (1)

Publication Number Publication Date
SK42593A3 true SK42593A3 (en) 1993-09-08

Family

ID=24427392

Family Applications (1)

Application Number Title Priority Date Filing Date
SK42593A SK42593A3 (en) 1990-10-31 1991-10-21 Antitusic agents

Country Status (13)

Country Link
EP (1) EP0555411A1 (cs)
JP (1) JPH06502428A (cs)
AU (1) AU663857B2 (cs)
CA (1) CA2129676C (cs)
CZ (1) CZ79593A3 (cs)
FI (1) FI931934A7 (cs)
HU (1) HUT64216A (cs)
IE (1) IE913792A1 (cs)
MX (1) MX9101831A (cs)
PL (1) PL168968B1 (cs)
PT (1) PT99380B (cs)
SK (1) SK42593A3 (cs)
WO (1) WO1992007559A1 (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1274026B (it) * 1994-03-01 1997-07-14 Acraf Composizione antitosse
SE9601528D0 (sv) * 1996-04-23 1996-04-23 Pharmacia Ab Transdermally administered dextromethorphan as antitissue agent
ES2196574T3 (es) 1997-07-15 2003-12-16 Walter Burghart Procedimiento para la preparacion de soluciones estables de acido acetilsalicilico.
US6245785B1 (en) 1998-11-30 2001-06-12 Warner Lambert Company Dissolution of triprolidine hydrochloride
US6846495B2 (en) * 1999-01-11 2005-01-25 The Procter & Gamble Company Compositions having improved delivery of actives
DE102007000521A1 (de) 2007-10-18 2009-04-23 Renate Conrad Hustenpräparat
US10888620B2 (en) 2016-11-28 2021-01-12 Johnson & Johnson Consumer Inc. Liquid compositions for treating cough or cold symptoms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4294819A (en) * 1980-08-18 1981-10-13 Bristol-Myers Company Alkaline analgesic capsule
US4454140A (en) * 1982-09-07 1984-06-12 Hoffmann-La Roche Inc. Nasal administration of dextromethorphan
US4427681A (en) * 1982-09-16 1984-01-24 Richardson-Vicks, Inc. Thixotropic compositions easily convertible to pourable liquids
US4892877A (en) * 1987-10-27 1990-01-09 Richardson-Vicks Inc. Antitussive liquid compositions containing phenol

Also Published As

Publication number Publication date
PL168968B1 (en) 1996-05-31
IE913792A1 (en) 1992-05-22
CA2129676C (en) 1997-09-30
AU8915891A (en) 1992-05-26
CA2129676A1 (en) 1992-05-14
PT99380A (pt) 1992-09-30
HUT64216A (en) 1993-12-28
JPH06502428A (ja) 1994-03-17
MX9101831A (es) 1992-06-05
EP0555411A1 (en) 1993-08-18
HU9301254D0 (en) 1993-07-28
CZ79593A3 (en) 1994-01-19
FI931934A0 (fi) 1993-04-29
FI931934L (fi) 1993-05-31
PT99380B (pt) 1999-04-30
WO1992007559A1 (en) 1992-05-14
AU663857B2 (en) 1995-10-26
FI931934A7 (fi) 1993-05-31

Similar Documents

Publication Publication Date Title
US5196436A (en) Dextromethorphan antitussive compositions
AU698718B2 (en) Taste masking liquids
CA2567075C (en) Pharmaceutical suspension composition
CA2042289C (en) Taste masking and sustained release coatings for pharmaceuticals
CN108187054B (zh) 新液体组合物的增强的稳定性
AU678858B2 (en) Controlled release potassium dosage form
WO2003047502A1 (en) Taste masked aqueous liquid pharmaceutical composition
HU211285A9 (en) Oral dosing formulations of dideoxy purine nucleosides
US4888343A (en) Pharmaceutical compositions for relief of dysmenorrhea and/or premenstrual syndrome and process
SK42593A3 (en) Antitusic agents
JP2002193839A (ja) ココア製剤
EP1303257B1 (en) Method of preparing a liquid unit dosage form and a kit
CN101756982B (zh) 一种改善口感且稳定的青蒿琥酯复方药物组合物
US5155105A (en) Pharmaceutical methods for relief of dysmenorrhea and/or premenstrual syndrome and process
JPH08239327A (ja) 慢性骨格筋疼痛の予防又は治療剤
US6075048A (en) Pediatric method of use of bambuterol
AU2001283191A1 (en) Compositions containing an inhibitor of dihydrofolate reductase and a folate
JP2000095707A (ja) 苦味を有する薬物を含有する口中溶解型又は咀嚼型固形内服医薬組成物
JP3150642B2 (ja) 新規な抗痙攣性及び抗炎症性組成物並びにそれらの製造方法
WO1995033451A1 (en) Non-sedating allergy sinus medication
WO2008098586A1 (en) Pharmaceutical carrier composition and pharmaceutical composition
HK1215685B (en) Enhanced stability of novel liquid compositions
HK1172252A (en) Pharmaceutical suspension composition